Revenues from all sources are welcome! When we examine the financial statements and cross-reference them with the data on new contracts, it becomes apparent that DM is in need of liquidity.
Whether these funds come from any vertical, they would be most welcome. Given that their sales team has identified opportunities in COVID testing, there's no reason to overlook these readily available opportunities!
The only concerning aspect is that this morning's press release indicates that DM is "assessing opportunities to resume COVID-19 testing." This might not be a wise move for an organization in their current position, especially when the entire market is eagerly awaiting the first AGPT sales numbers.
It would have been safer to wait until they had thoroughly assessed the market before making such an announcement. Now that it's been done, the market must live with it and adjust to the uncertainty it creates.
Hopefully, we can look forward to future press releases with concrete positive information in the near future.